CATEGORY: Press Release

Aclarion Appoints Nicholas Theodore, MD as Principal Investigator for CLARITY Post-Market Trial

Nicholas Theodore, MD, FACS, FAANS, is Director of Neurosurgical Spine Center, Johns Hopkins, and Professor of Neurosurgery, Orthopaedics and Biomedical Engineering CLARITY is a post-market, multi-site trial, that will further evaluate the role of Nociscan in the diagnosis and surgical treatment of chronic low back pain. CLARITY is targeted to begin in the second half […]

Aclarion Announces Publication of 2YR Outcomes in Groundbreaking Clinical Trial

  Success rate at 2 years for discogenic low back pain surgeries was 85% for patients whose treatment strategy was consistent with Nociscan-identified discs, a 22 percentage point improvement over patients whose treatment strategy was inconsistent with Nociscan-identified discs (85% vs. 63%; p=0.07) Nociscan is the first augmented intelligence platform to measure pain biomarkers in […]

Aclarion Announces Alpesh Patel MD MBA as a Key Opinion Leader Physician Advisor

Marks the eighth advisor to growing KOL program to build strong body of clinical evidence and support US commercialization Aclarion to participate in upcoming SPINEWEEK 2023   Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location […]

Aclarion Supports Thought Leadership at the 2nd Annual Sonntag Spine Symposium

NociscanTM is the first evidence-supported SaaS platform to objectively measure discogenic biomarkers for insight into pathological pain. Nociscan provides decision support to help bridge a major diagnostic void. Robert Eastlack, MD will speak to his real-world experience using Nociscan to effectively evaluate CLBP.   Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare […]

Gregory Basil MD to Join Aclarion as a Key Opinion Leader Surgeon Advisor

Director of Endoscopic Spine Surgery at the University of Miami Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain, announced today that Gregory Basil, MD, Director of Endoscopic Spine Surgery at […]

Aclarion Appoints George Frey MD as Seventh Key Opinion Leader Surgeon Advisor

Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain, announced today that George Frey MD, Founder of the Colorado Comprehensive Spine Institute will advise the company as a key opinion leader […]

Dr. Christopher Ames to Join Aclarion as a Key Opinion Leader Surgeon Advisor

Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain, announced today that Dr. Christopher Ames, Director of Spinal Deformity and Spine Tumor Surgery and Co-Director of the Combined High Risk Spine […]

Aclarion’s Key Opinion Leader Program Adds Fifth Surgeon Advisor with Addition of Eric Potts, MD

Development of this program supports Aclarion’s commitment to lead with strong clinical evidence and engage the payer community through key opinion leader advocacy.   Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low […]

Aclarion Adds to Growing Key Opinion Leader Program with Juan Uribe M.D. as a Surgeon Advisor

Dr. Uribe is the fourth national KOL to join the Aclarion team this year. Development of this program supports Aclarion’s commitment to lead with strong clinical evidence and engage the payer community through key opinion leader advocacy. December 19, 2022, Broomfield, CO – Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology […]

Request Info or Schedule a Demo

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Aclarion
8181 Arista Place,
Suite 100
Broomfield, CO 80021

info@aclarion.com

833-ASK-ACON (833-275-2266)

GD USA 2023 Award
GD USA Health & Wellness 2023 Award